The family that found Purdue Pharma has come under intense scrutiny as of late after it was revealed just how deeply involved some of the members were in the early aggressive marketing tactics pursued by the opioid-maker. Meanwhile, an advocacy group is calling on the FDA to impose a moratorium on approving new opioids.
from Kaiser Health News https://ift.tt/2HA7TKM
March 22, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
In Rapidly Evolving Health Care Landscape, Traditional Borders Are BlurringHospitals' recent decisions to start making their own drugs is just one in a long string of actions taken within the industry to break down conventional roles. from Kaiser Health News http://ift.tt/2DZ050y … Read More
Not All Screen Time May Be Harmful To Kids, Some Experts Begin To ConsiderThe standard these days is to recommend children limit time in front of screens. But there's a difference between passive exposure and active interaction. In other public health news: transgender children, Tide Pods, gene-edi… Read More
California Lawmakers Expected To Introduce Legislation To Fortify State’s Health Exchange“Everything they are doing at the federal level, we are doing the opposite,” said state Sen. Ed Hernandez. Meanwhile in Wisconsin, Gov. Scott Walker shifts toward the center with proposal to use money to stabilize the state's… Read More
IV Bag Shortage In Midst Of Vicious Flu Season Exposes Flaw In Health System’s Crisis ResponseA shortage of crucial supplies can lead to "potentially dangerous treatment of patients," rising death rates and overwhelmed emergency workers and nursing facilities. Media outlets report on news of the flu out of California,… Read More
Most People Who Overdose Don’t Die. Instead They’re Ensnared In Relentless Cycle Of Worry And Chaos.Although the nation has been transfixed by the horrifying statistics about drug overdoses, that's not the reality most people who are addicted to opioids are experiencing. Instead they're caught up in a grinding, consuming an… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment